World First Malaria Vaccine Approved
The world's first malaria vaccine has received a green light from European drugs regulators who recommended it should be licensed for use in babies in Africa who are at risk of the mosquito-borne disease. The shot, called RTS,S or Mosquirix, would be the first licensed human vaccine against a parasitic disease and could help prevent millions of cases of malaria in countries that use it. The vaccine was developed by British drugmaker GlaxoSmithKline (GSK) in partnership with the PATH Malaria Vaccine Initiative, Recommendations for a drug licence made by the European Medicines Agency (EMA) are normally endorsed by the European Commission within a couple of months. Mission Malaria Mosquirix, also part-funded by the Bill & Melinda Gates Foundation, will also now be assessed by the World Health Organisation, which has promised to give its guidance on when and where it should be used before the end of this year. Malaria killed an estimated 584,000 people in 2013, the vast maj...